Your SlideShare is downloading. ×
ACI's 4th Annual Biosimilars Forum
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Saving this for later?

Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime - even offline.

Text the download link to your phone

Standard text messaging rates apply

ACI's 4th Annual Biosimilars Forum

612
views

Published on


0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
612
On Slideshare
0
From Embeds
0
Number of Embeds
3
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide
  • *
  • Transcript

    • 1. 1st 2nd3rd 4thJune 5-7, 2013 - AgendaTo learn more and register Click HereDrawing on 3 years of top-notch programming, ACI’s 4th Annual Biosimilarsprogram remains the industry’s leading legal and regulatory event.FTC Spotlight: Addressing the AntitrustConcerns Resulting from Follow-On LegislationSuzanne Drennon Munck, Counsel forIntellectual Property, Federal TradeCommission.Insights from over 20 companies including a keynoteaddress from Merck on Branding and PromotionalConsideration for Biosimilars.Industry insights into when the first applications willbe forthcoming from over two dozen companiesincluding Eli Lilly, Astra Zeneca, Genentech, and Pfizer.Keynote Address from: Denise Esposito , DeputyAssociate Director for Policy, Office of RegulatoryPolicy ( ORP), CDER Food & Drug Administration(FDA).AmericanConference.com/biosimilars